Other functions preclinical in vitro and in vivo screening for cancer preventive agents development

Ended Definitive Contract Awarded Apr 30, 2004 Last action Jul 30, 2015

Contract number: HHSN261200433000C
Awardee: University Of Toledo UEI XA77NAJYELF1
Awarding agency: National Cancer Institute National Institutes of Health, Department of Health and Human Services
Obligated: $8,284,922

Award facts

Opportunity: N01CN2502676 Solicitation number
Contract value 27% obligated: $8,284,922.07 Current, with exercised options

$30,992,368.00 Potential, with all options
Completion date 100% complete: Jun 30, 2013 Current and potential, with all options
NAICS code: Not on record
PSC: AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside: No set-aside
Competition: Full and Open Competition · 6 offers
Pricing: Cost No Fee
Place of performance: Toledo, OH 43614, USA

Award details come from SAM.gov/FPDS.

Transactions

Action	Obligated	Date
Other Administrative Action 13	-$344,985	Jul 30, 2015
Other Administrative Action 12 · Preclinical in vitro and in vivo screening assays for cancer preventive agent development	$425,868	Aug 26, 2013
Other Administrative Action 11 · Final_close_process - preclinical in vitro and in vivo screening assays for cancer preventive agent development	-$425,868	Aug 13, 2013
Other Administrative Action 10 · Preclinical invitro and invivo screening assays for cancer preventative agent development	$0	Jul 15, 2013
Other Administrative Action 9 · Other functions	$0	Sep 28, 2012
Other Administrative Action 8	$0	Mar 31, 2011
Funding Only Action 7 · Other functions	$1,508,051	Sep 24, 2010
Supplemental Agreement for work within scope 6	$1,454,476	Jul 8, 2009
Funding Only Action 4 · Preclinical in vitro and in vivo screening for cancer preventive agents development	$1,062,768	Jul 9, 2008
Vendor Address Change 3	$983,472	Sep 20, 2007
Modification	$905,285	Mar 10, 2004
Modification 2	$905,285	Mar 10, 2004
Modification 1	$905,285	Mar 10, 2004
Original award 5	$905,285	Mar 10, 2004

Show all 14

About this award

Written by GovTribe AI · Nov 24, 2024

This is a $30,992,368 definitive cost-no-fee contract awarded by the National Cancer Institute to the University of Toledo for other functions, preclinical in vitro and in vivo screening for cancer preventive agents development. The contract has an ultimate completion date of June 30, 2013 and does not have a set-aside designation. The University of Toledo is a public research university that frequently receives federal contract and grant awards to conduct research and provide educational services across various fields. This contract supports the university's work in cancer research and development for the National Cancer Institute. The University of Toledo has been awarded numerous federal research grants and contracts, both as a prime recipient and as a subcontractor, to support the missions of agencies such as NASA, NOAA, the Department of the Air Force, and the Department of the Navy.

Quick answers

Who was awarded contract HHSN261200433000C?

HHSN261200433000C was awarded to University Of Toledo by National Cancer Institute (National Institutes of Health) on April 30, 2004.

How much is contract HHSN261200433000C worth?

The government has obligated $8,284,922 on HHSN261200433000C. Its potential value, with all options, is $30,992,368.

Was contract HHSN261200433000C competed?

The extent of competition for HHSN261200433000C was full and open competition. The government received 6 offers.

On GovTribe

See this award's full record

Every transaction and funding action
The awardee's other awards and teaming partners
Similar awards and recompete opportunities
Ask GovTribe AI about this award

Try for free Login